Viral Hepatitis

 

Viral hepatitis is a global public health problem that affects millions of people worldwide each year, causing disability and death. Appropriate measures such as vaccination, safe injections, a safe diet, and a safe blood supply can reduce the rate of transmission of viral hepatitis. Many of these measures not only reduce the transmission of viral hepatitis but also affect the prevention of various other communicable diseases. Additionally, current treatments for hepatitis B and C provide healthcare providers with powerful tools to combat the disease. New advanced antiretroviral drugs such as TDF, 3TC, and FTC are effective in treating HIV and HBV infections. Co-infection therapy for hepatitis B and hepatitis C is also being developed, and the future looks brighter than ever. d The patient can take fewer medications to treat these two conditions for her. Viral hepatitis can also be prevented by timely vaccination and good hygiene.

·         Screening Tests

·         Antiretrovirals

·         Safe Injection Practices

·         Blood Safety Strategies

·         Assessment and Management of Chronically Infected Persons

·         Personal and Community Health

·         Antivirals Such as Lamivudine and Adefovir

·         Pegylated Interferon Injections

  • Antiretrovirals
  • Blood Safety Strategies

Related Conference of Viral Hepatitis

March 13-14, 2025

9th International Conference on Rare Diseases

Prague, Czech Republic
March 17-18, 2025

12th International Congress on Infectious Diseases

Berlin, Germany
April 14-15, 2025

15th European Epidemiology and Public Health Congress

Budapest, Hungary
June 02-03, 2025

14th World Congress on Rare Diseases and Orphan Drugs

Amsterdam, Netherlands
June 02-03, 2025

17th Euro-Global Conference on Infectious Diseases

Amsterdam, Netherlands

Viral Hepatitis Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in